Enlivex, a Nasdaq-listed biotechnology firm, is asking shareholders to authorize as much as $800 million of financing tied to the $RAIN crypto token. The construction might enhance its share depend by as a lot as 951%.
Regardless of Enlivex’s biotech enterprise, the financing is primarily a crypto-treasury transaction. $RAIN delivered at closing would go to the corporate’s treasury wallets, whereas considerably all money or stablecoin proceeds are earmarked to accumulate the token or help different treasury functions, transaction prices, and debt. Solely as much as 5% of remaining USD proceeds might fund Allocetra.
Shareholder approval is required for an preliminary $400 million placement and the utmost securities accessible underneath a separate, company-controlled $400 million choice. The primary tranche alone might equal roughly 4 to 5 instances Enlivex’s newest disclosed shares excellent.
Enlivex stated in a Kind 6-Ok that it might use commercially affordable efforts to name and maintain the assembly inside 60 days of its July 27 settlement.
Beneath the securities buy settlement, the investor elected to pay within the $RAIN token however can change that alternative earlier than closing. $RAIN consideration carries a $6 complete worth per ordinary-share equal, whereas USD, $USDT, or $USDC carries a $5 worth.
The general public paperwork don’t clearly determine the customer. The 6-Ok calls it Rain Basis, whereas the settlement defines Token Issue Basis because the lead investor and leaves the general public purchaser signature block clean. The filings don’t set up whether or not the 2 names consult with the identical entity.
Dilution will depend on the fee technique
If the primary tranche is paid fully in $RAIN, it represents about 66.7 million odd shares or underlying pre-funded-warrant shares. Fee fully in money or stablecoins would symbolize 80 million. Enlivex stated in a July 7 submitting that its 1-for-15 reverse cut up would cut back issued and excellent shares to roughly 16.83 million.
The preliminary issuance subsequently equals about 396% of that baseline on the $RAIN worth or 475% on the cash-like worth. On a share-equivalent foundation, present holders would account for roughly 20.2% or 17.4% of the enlarged complete, respectively.
The comparability makes use of issued and excellent shares as a result of the filings present no present absolutely diluted depend. Enlivex’s newest detailed choice and warrant desk is dated Dec. 31, 2025, whereas a later Lind financing permits variable share issuance, so these historic figures can not safely be mixed with the July depend.
Full use of the elective second tranche underneath one fee technique would carry complete new share equivalents to about 133.3 million on the $RAIN worth or 160 million on the cash-like worth. That’s roughly 792% or 951% of the present excellent baseline, leaving current holders at about 11.2% or 9.5% of the ensuing share-equivalent complete.
Pre-funded warrants don’t take away that overhang. They’re instantly exercisable and don’t expire, though beneficial-ownership limits can delay train.
The vote should cowl securities for each the preliminary closing and the utmost put underneath Israeli legislation and Nasdaq guidelines. After closing, Enlivex could compel the lead investor to purchase as much as one other $400 million of shares or pre-funded warrants over so long as 36 months. The investor can not demand that second buy, and Enlivex shouldn’t be assured the extra proceeds.
The proceeds favor $RAIN over Allocetra
Considerably all web proceeds paid in USD, $USDT, or $USDC are earmarked for buying $RAIN, different treasury functions, transaction prices, and excellent debt. Solely as much as 5% of USD web proceeds remaining after charges, bills, and debt could fund Allocetra. $RAIN delivered at closing goes to the corporate treasury wallets.
$RAIN amount shall be set from CoinMarketCap’s common closing worth over the 5 enterprise days earlier than closing. That calculation doesn’t set up realizable money worth. CryptoSlate’s point-in-time $RAIN market web page confirmed about $29.88 million in 24-hour reported quantity, making $400 million roughly 13.4 instances in the future’s turnover. Reported quantity shouldn’t be executable liquidity.
